Publication Type:

Journal Article

Source:

Pharmacogenomics, Volume 19, Issue 3, p.227-241 (2018)

Abstract:

<p><strong>AIM: </strong>Adverse drug reactions to 5-Fluorouracil(5-FU) is frequent and largely attributable to genetic variations in the DPYD gene, a rate limiting enzyme that clears 5-FU. The study aims at understanding the pharmacogenetic landscape of DPYD variants in south Asian populations.</p>

<p><strong>MATERIALS &amp; METHODS: </strong>Systematic analysis of population scale genome wide datasets of over 3000 south Asians was performed. Independent evaluation was performed in a small cohort of patients.</p>

<p><strong>RESULTS: </strong>Our analysis revealed significant differences in the the allelic distribution of variants in different ethnicities.</p>

<p><strong>CONCLUSIONS: </strong>This is the first and largest genetic map the DPYD variants associated with adverse drug reaction to 5-FU in south Asian population. Our study highlights ethnic differences in allelic frequencies.</p>

Cite this Research Publication

J. M. Hariprakash, Vellarikkal, S. K., Keechilat, P., Verma, A., Jayarajan, R., Dixit, V., Ravi, R., Senthivel, V., Kumar, A., Sehgal, P., Sonakar, A. K., Ambawat, S., Giri, A. K., Philip, A., Sivadas, A., Faruq, M., Bharadwaj, D., Sivasubbu, S., and Scaria, V., “Pharmacogenetic landscape of DPYD variants in south Asian populations by integration of genome-scale data.”, Pharmacogenomics, vol. 19, no. 3, pp. 227-241, 2018.

207
PROGRAMS
OFFERED
6
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS